Sponsors

Disease map

French genomics company IntegraGen has discovered a groundbreaking method of identifying causal disease genes, with the aid of Applied BiosystemsÆ custom assays and the SNPIex genotyping system.

Its gene-mapping technology û genome hybrid identity profiling (GenomeHIP) û works on the assumption that the same disease genes will be found in related individuals with the same disease, so the disease loci can be mapped by removing non-identical DNA sequences the genomes share. J÷rg Hager, IntegraGenÆs chief scientific officer, explained how Applied BiosystemsÆ products have helped: ôFor any disease in a given population, we identify up to seven potential disease loci, assemble a panel of region-specific SNPs and have assays manufactured by Applied Biosystems. Within a couple of days we can use the assays to analyse a large number of individuals using the SNPIex Genotyping System.ö

Latest Issues

BSMT 41st Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
21 May, 2026

Clinical and Laboratory Haemostasis 2026

Sheffield Hallam University Atrium Conference Centre, Sheffield S1 1WB
3-4 June, 2026

LabMedUK26

The Eastside Rooms conference centre, Birmingham
8-10 June, 2026

London Biotechnology Show

Excel, London
9-10 June, 2026

Weqas Annual Laboratory Conference 2026

St Andrew’s Stadium, Birmingham
11th June 2026